Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a year earlier, while its quarterly net loss narrowed to US$108.12 million and ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

After eight episodes of post-apocalypse insanity and plenty of irradiated creatures, Fallout wrapped up Season 2 with the season finale, “The Strip,” this week. Given that multiple characters are left ...

Donald Trump’s Department of Justice faced one of its harshest judicial rebukes so far, at an explosive Monday hearing that laid bare the disturbing incompetence and contempt currently plaguing the ...

Anthropic’s Claude Opus 4.6 introduces "Adaptive Thinking" and a "Compaction API" to solve context rot in long-running agents. The model supports a 1M token context window with 76% multi-needle ...

Once you've conquered the Pizzaplex for a second time in Five Nights at Freddy's: Security Breach - Ruin, your first thought will probably be: "Well, what on Earth just happened?" After all, It wouldn ...

The term “AI” has been used in computer science since the 1950s, but most people outside the industry didn’t start talking about it until the end of 2022. That’s because recent advances in machine ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...